You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Glandular and Epithelial

Showing 1 - 25 of 4,397
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • +8 more
  • AB-1015
  • Iowa City, Iowa
    U. of Iowa Health Care
Jan 30, 2023

Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))

Recruiting
  • Epithelial Tumors, Malignant
  • MT-302 (A)
  • Randwick, New South Wales, Australia
    Scientia Clinical Research Ltd
Aug 1, 2023

Cancer Trial (single arm for all patients)

Not yet recruiting
  • Cancer
  • single arm for all patients
  • (no location specified)
Sep 26, 2022

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Glioma, Recurrence, Disease Attributes Trial (Vorasidenib)

Available
  • Glioma
  • +10 more
  • (no location specified)
Oct 19, 2022

Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation

Recruiting
  • Tumor Recurrence
  • +3 more
  • carbon ion radiation therapy
  • Pavia, Pv, Italy
    CNAO
Jul 13, 2022

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed
  • Carcinoma
  • +12 more
  • Ocoxin-Viusid
  • Havana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022

Carcinoma, Neoplasia; Intraepithelial, Cervix, Glandular Tumors Trial in Havana (Glizigen® + Ocoxin-Viusid®)

Recruiting
  • Carcinoma
  • +4 more
  • Glizigen® + Ocoxin-Viusid®
  • Havana, Cuba
    Our Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
Jul 5, 2022

Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Tumors Trial in San Francisco (Parathyroid Eye (PTeye))

Active, not recruiting
  • Parathyroid Diseases
  • +9 more
  • Parathyroid Eye (PTeye)
  • San Francisco, California
    University of California, San Francisco
Jul 27, 2022

Overall Survival in Unresectable Hepatocellular Carcinoma

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Osaka, Japan
  • +1 more
Mar 7, 2022

Carcinoma, Hepatocellular, Liver Tumors, Tumors, Glandular and Epithelial Trial in Nanning (Hepatic Resection, Radiofrequency

Recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hepatic Resection
  • Radiofrequency Ablation
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 14, 2022

Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641
  • Los Angeles, California
  • +5 more
Jan 16, 2023

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Locally Advanced or Metastatic Epithelial Tumor Trial in Guangzhou (SI-B001)

Active, not recruiting
  • Locally Advanced or Metastatic Epithelial Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 14, 2022

Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)

Recruiting
  • Epithelial Tumor
  • Metastatic Cancer
  • NG-350A plus Pembrolizumab
  • Santa Monica, California
  • +3 more
May 4, 2022

Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641 in combination with Nivolumab
  • Santa Monica, California
  • +2 more
Mar 16, 2022

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Epithelial Tumors, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor Trial run by the NCI (NHS-IL-12)

Completed
  • Epithelial Neoplasms, Malignant
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 15, 2021

Epithelial Tumors, Malignant, Malignant Solid Tumor Trial in Barcelona (NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD)

Recruiting
  • Epithelial Tumors, Malignant
  • Malignant Solid Tumor
  • NEXTGEN-TIL
  • +2 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Nov 25, 2021

Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

Not yet recruiting
  • Solid Tumors
  • +8 more
  • Magnetic Resonance-Guided High Intensity Focused Ultrasound
  • Lyso-thermosensitive Liposomal Doxorubicin
  • (no location specified)
Mar 10, 2022

Endometrial Cancer Trial in New York (Carboplatin AUC, Abraxane)

Completed
Has Results
  • Endometrial Cancer
  • New York, New York
    NYU Perlmutter Cancer Center
Apr 20, 2021